Nobody likes to pay more than they have to to treat their horses but there is a difference in regulatory over-site between "veterinary devices" used as drugs (none) and FDA approved drugs (proven efficacy, quality control inspection).
Saturday, January 26, 2013
Good article from the Chonicle on Veterinary Drugs and "Veterinary Devices"
Nobody likes to pay more than they have to to treat their horses but there is a difference in regulatory over-site between "veterinary devices" used as drugs (none) and FDA approved drugs (proven efficacy, quality control inspection).
New York Times article on (over)medication of show horses
(copy and paste to command line)
The article speaks for itself quite well. There are a lot of subjects for discussion here, from how we treat our horses to the influence of money on the horse community. Some of us were a little smug when it was the race horse industry under the microscope. This hits a little closer to home. If you don't like the status quo and you are a member of the USEF, make your feelings known. The USEF (formerly AHSA) drug rule started out as a simple, useful regulation to allow reasonable and humane treatment of competition horses while banning drugs that would affect performance or hurt the health of the horse. Some owners, trainers, and unfortunately veterinarians continue to push the envelope in an effort to gain an "edge" resulting in a more and more complicated set of rules.
Saturday, August 25, 2012
West Nile Encephalitis
Wednesday, June 20, 2012
Acclimitizing to heat and humidity
Friday, June 15, 2012
USDA office in Annapolis to close 6/29
Saturday, March 3, 2012
Carolina Gold - GABA prohibited by USEF
RELEASE: February 22, 2012
AUTHOR/ADMINISTRATOR: USEF Communications Department
Tasked with protecting the welfare of equine athletes and ensuring the balance of competition, the USEF Equine Drugs and Medications Program consistently monitors new products and product claims. From time-to-time products appear on the equine supplement market making claims of their effects on the performance of horses in competition.
Recently, reports of the use of a product called “Carolina Gold” have been brought to the USEF Equine Drugs and Medications Program. One of the principal constituents of this product is gama aminobutyric acid (GABA), an inhibitory neurotransmitter.
While initially not considered a forbidden substance, the use of GABA as a “calming supplement” does violate the spirit and intent of the Equine Drugs and Medications Rule. During recent research and administration trials involving “Carolina Gold,” many adverse reactions were documented. The nature of these reactions has prompted immediate action from the USEF Equine Drugs and Medications Program.
Effective immediately, “Carolina Gold” or any other product containing GABA is considered a forbidden substance under USEF rules. Further, because there are no recognized medical uses for this substance, the use of a Medication Report Form to report its administration is not applicable.
The detection of GABA is being actively pursued by the USEF Equine Drugs and Medications Program and will be implemented without delay or notice. No further announcements will be forthcoming regarding the use of “Carolina Gold” or GABA. All positive findings will be forwarded to the USEF Hearing Committee. Trainers and veterinarians involved in the sale or use of this substance may be subject to fines and/or suspensions.
Friday, February 24, 2012
Management of insulin resistance with supplements
Insulin resistance (this is now the preferred term over "metabolic syndrome") is related to multiple health issues in horses, particularly an increased incidence of laminitis. Several supplements on the market are marketed to help control insulin resistance in horses with magnesium and chromium. This study, done at New Bolton Center and University of Tennessee College of Veterinary Medicine, indicates that these do not have a measurable effect on affected horses and ponies.
Effects of a supplement containing chromium and magnesium on morphometric measurements, resting glucose, insulin concentrations and insulin sensitivity in laminitic obese horses
- K. A. CHAMEROY,
- N. FRANK*,
- S. B. ELLIOTT,
- R. C. BOSTON
Article first published online: 29 SEP 2010
DOI: 10.1111/j.2042-3306.2010.00302.x
© 2010 EVJ Ltd
results and conclusion:
Results: Hyperinsulinaemia (>30 µu/ml) was detected in 12 of 14 horses prior to treatment. Glucose and insulin data from one mare with clinical laminitis were excluded because of persistent pain. Mean ± s.d. insulin sensitivity was 0.64 ± 0.62 × 10−4 l/min/mu prior to treatment for the remaining 13 horses. Time and treatment × time effects were not significant for any of the variables examined, with the exception of resting insulin concentrations, which significantly increased over time (P = 0.018). Health status remained the same.
Conclusions: The supplement containing chromium and magnesium evaluated in this study did not alter morphometric measurements, blood variables, resting insulin concentrations or insulin sensitivity in laminitic obese horses.
Unfortunately weight loss through diet and exercise is the only proven disease modifier. We all like to please our horses and enjoy seeing them enjoy their food but any horse will lose weight if the calorie intake is reduced enough. Total starvation is a very bad idea and will cause other problems, particularly in obese horses.